文献速递冠心病血脂与心血管预防

单细胞多组学识别免疫风险与心血管结局

Immunological risk identified by single-cell multi-omics and cardiovascular outcomes.
PubMed 文献 · Eur Heart J · 2026-08-14

多组学因子分析揭示与传统生物标志物无关的免疫信号,包括T细胞增殖特征,与CAD状态和心血管死亡相关,并在两个独立队列中验证。

要点

  • 单细胞多组学可识别hsCRP和IL-6之外的免疫风险信号
  • T细胞增殖特征与CAD状态及长期生存相关
  • 该信号独立于髓系来源的hsCRP和IL-6

核心结论

  • 血液免疫细胞多组学分析揭示与CAD及短期和长期心血管结局相关的新免疫特征,独立于系统性炎症,未来可能用作风险分层工具。

研究设计与样本

  • 在LURIC单中心前瞻性队列(3316例)内进行嵌套病例对照研究。
  • 采用bulk RNA、单细胞RNA、单细胞T细胞受体测序、质谱流式、空间成像和细胞因子分泌检测。
  • 应用多组学因子分析识别共享转录程序,并在两个独立队列中验证。

主要发现

  • 整合分析策略揭示常规生物标志物无法检测的免疫信号,包括T细胞中与激活、记忆形成、克隆扩增、干扰素信号和细胞因子分泌相关的显著细胞增殖特征。
  • 识别出与CAD状态和不良长期生存相关的细胞类型和转录程序。
  • 这些关联独立于髓系细胞来源的既定炎症标志物hsCRP和IL-6。
  • 关键发现使用136个单细胞RNA测序数据集在独立队列中重复验证。
  • 细胞增殖在动脉粥样硬化斑块中通过蛋白验证确认,特征被评估作为预测急性冠脉综合征短期结局的分层工具。

临床怎么用

  • 单细胞多组学免疫特征可能作为CAD和心血管死亡的风险分层工具,独立于hsCRP和IL-6。
  • T细胞增殖相关信号值得在急性冠脉综合征短期结局预测中进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: While inflammation and (auto-)immunity are modifiers of atherosclerosis, immunological determinants of cardiovascular risk beyond the established inflammatory markers, high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) remain incompletely defined in humans. This exploratory proof-of-concept study aimed to detect immunological signals enriched in patients with increased cardiovascular risk. METHODS: A nested case-control study was performed within the Ludwigshafen Risk and Cardiovascular Health (LURIC) cohort, a single-centre prospective study of 3316 patients. Forty-four individuals with and without angiographically confirmed coronary artery disease (CAD) and defined survival status were selected for comprehensive immunophenotyping employing bulk RNA, single-cell RNA (scRNA), single-cell T-cell receptor sequencing, mass cytometry, spatial imaging, and cytokine secretion in blood immune cells. Multi-omics factor analysis was applied to identify shared transcriptional programmes. Readouts were tested for their association with CAD status and cardiovascular mortality and validated in two independent cohorts. RESULTS: The integrated analysis strategy revealed immunological signals not detectable with conventional biomarkers, including a prominent signature of cellular proliferation, linked to activation, memory formation, clonal expansion, interferon signalling, and cytokine secretion in T cells. Cell types and transcriptional programmes associated with CAD status and poor long-term survival were identified. These associations were independent of established inflammatory markers, hsCRP and IL-6 that originated from myeloid cells. Key findings were replicated across independent cohorts using 136 scRNA sequencing datasets. Cellular proliferation was confirmed by protein validation in atherosclerotic plaques, and signatures were evaluated as stratification tools to predict short-term outcomes in acute coronary syndromes. CONCLUSIONS: Multi-omic profiling of blood immune cells revealed novel immune signatures associated with CAD, short- and long-term cardiovascular disease outcomes that are independent of systemic inflammation and may be used as risk stratification tools in the future.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Horstmann H, Anto Michel N, Losert C, et al. Immunological risk identified by single-cell multi-omics and cardiovascular outcomes. Eur Heart J. 2026. PMID: 42596600. doi:10.1093/eurheartj/ehag553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。